oncnursingnews1h
Addition of Concomitant TTFields Induces OS Benefit in Unresectable Pancreatic Cancer
The phase 3 PANOVA-3 trial, designed to evaluate concomitant treatment with tumor treating fields and chemotherapy, met its ...
oncnursingnews22h
FDA Approves First and Only Systemic Therapy for NRG1+ Lung, Pancreatic Cancers
Zenocutuzumab received accelerated approval from the FDA for the agent to treat non-small cell lung cancer (NSCLC) or ...